Search
Tanuxiciclib
go.drugbank.com/drugs/DB21504ExperimentalTanuxiciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Tanuxiciclib is a cyclin dependant kinase inhibitor.
Asnuciclib
go.drugbank.com/drugs/DB21530ExperimentalAsnuciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Asnuciclib is a cyclin dependant kinase inhibitor.
Neracorvir
go.drugbank.com/drugs/DB21630ExperimentalNeracorvir is a small molecule drug. The usage of the INN stem '-corvir' in the name indicates that Neracorvir is a core protein (Cp) inhibitor.
Tacaciclib
go.drugbank.com/drugs/DB21644ExperimentalTacaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Tacaciclib is a cyclin dependant kinase inhibitor.
Fovinaciclib
go.drugbank.com/drugs/DB21721InvestigationalFovinaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor.
Zeprumetostat
go.drugbank.com/drugs/DB21740InvestigationalZeprumetostat is a small molecule drug. The usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor.
Avotaciclib
go.drugbank.com/drugs/DB16652InvestigationalAvotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
HX-1171
go.drugbank.com/drugs/DB12162InvestigationalHx 1171 is under investigation in clinical trial NCT01548391 (A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects).
Risuteganib
go.drugbank.com/drugs/DB14911InvestigationalRisuteganib is under investigation in clinical trial NCT02348918 (Phase 2 Randomized Clinical Trial of LuminateĀ® as Compared to AvastinĀ® in the Treatment of Diabetic Macular Edema).
GTI-2040
go.drugbank.com/drugs/DB15030ExperimentalGTI-2040 is under investigation in clinical trial NCT00084643 (GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors).